Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| Substance P-methyl ester | C64H99N17O14S | 76260-78-1 | Details |
| TNF-α (46-65) (human) | C110H172N24O30 | 144796-72-5 | Details |
| TNF-α (10-36) (human) | C131H211N43O38 | 144796-70-3 | Details |
| TRH | C16H22N6O4 | 24305-27-9 | Details |
| TRH-Gly | C18H24N6O6 | 85344-77-0 | Details |
| Tyrosinase (243-251) (human) | C44H68N10O18S2 | 197171-78-1 | Details |
| Hepcidin-20 (human) trifluoroacetate salt | C85H135N27O23S9 | 342790-23-2 | Details |
| Hepcidin-22 (human) trifluoroacetate salt | C99H151N29O25S9 | 342790-22-1 | Details |
| Urocortin III, mouse | C186H312N52O52S2 | 357952-10-4 | Details |
| Urocortin III, human | C185H307N53O50S2 | 357952-09-1 | Details |
| TNF-α (31-45), human | C69H122N26O22 | 144796-71-4 | Details |
| [Trp11] Neurotensin (8-13) | C78H121N21O20 | 39379-15-2 | Details |
| Neurotensin (8-13) | C38H64N12O8 | 60482-95-3 | Details |
| [D-Trp11]-Neurotensin | C80H122N22O19 | 73634-68-1 | Details |
| Neurotensin (8-13), N-Acetyl | C40H66N12O9 | 74853-69-3 | Details |
| [Lys8,Lys9]-Neurotensin (8-13) | C38H64N8O8 | 139026-64-5 | Details |
| [Arg8]-Vasopressin | C46H65N15O12S2 | 113-79-1 | Details |
| [Arg8]-Vasopressin (free acid) | C46H64N14O13S2 | 25255-33-8 | Details |
| [Arg8,des-Gly-NH29]-Vasopressin | C44H61N13O12S2 | 37552-33-3 | Details |
| Val-Asp-(Arg8)-Vasopressin | C55H78N16O17S2 | 100930-18-5 | Details |
| VIP, guinea pig | C147H239N43O42S2 | 96886-24-7 | Details |
| [Ala11,22,28]-VIP (human, bovine, porcine, rat) | C139H231N43O39S | 291524-04-4 | Details |
| VIP (1 - 12), human, porcine, rat | C61H88N18O22 | 120928-03-2 | Details |
| Vasoactive Intestinal Contractor [VIC] | C116H165N27O32S4 | 120928-04-3 | Details |
| Prepro VIP (156-170) (human) | C71H106N16O31 | 107902-86-3 | Details |
| VIP (6-28) (human, bovine, porcine, rat) | C126H207N37O34S | 69698-54-0 | Details |
| VIP (10-28) (human, bovine, porcine, rat) | C105H180N32O26S | 69856-17-3 | Details |
| [Pyr16]-VIP (16-28) (human, bovine, porcine, rat) | C68H114N18O18S | 134907-86-1 | Details |
| Xenopsin (XP) | C47H73N13O10 | 51827-01-1 | Details |
| Xenopsin-Related Peptide 1 (XP-1) | C51H79N15O9 | 117442-28-1 | Details |
| Urocortin II, human | C196H340F3N63O56S | 398001-88-2 | Details |
| [Arg8]-Vasopressin (4-9) | C25H44N12O8S | 96027-30-4 | Details |
| F-M-R-F | C29H41N7O5S | 74012-06-9 | Details |
| K-G-D-S | C15H27N5O8 | 93674-95-4 | Details |
| Urotensin II , human | C64H85N13O18S2 | 251293-28-4 | Details |
| Cathepsin S substrate | C41H66N12O9 | 1135686-31-5 | Details |
| Ac-Phe-Gly-pNA | C19H20N4O5 | 34336-99-7 | Details |
| cAMP Dependent Protein Kinase Substrate | C31H58N14O9 | 65189-70-0 | Details |
| [Ser25] - PKC (19 - 36) Substrate | C93H159N35O25 | 113715-84-7 | Details |
| PKCe pseudosubstrate derived peptide | C83H155N39O21S | 120253-69-2 | Details |
| Abl Cytosolic Substrate | C64H101N15O16 | 168202-46-8 | Details |
| Ac-IETD-pNA | C27H38N6O12 | 219138-21-3 | Details |
| Ac-VEID-pNA | C28H40N6O11 | 189684-54-6 | Details |
| Ac-IEAR-pNA | C26H34N6O13 | 189950-66-1 | Details |
| Z-Ala-Ala-Leu-pNA | C26H33N5O7 | 61043-33-2 | Details |
| Calcineurin Substrate | C92H150N28O29 | 113873-67-9 | Details |
| [D-Ala4]-Substance P (4-11) | C44H65N11O10S | 81381-50-2 | Details |
| [D-Glu5,D-Trp7,9,10]-Substance P (5-11) | C57H66N12O10S | 289632-61-7 | Details |
| [Pyr6]-Substance P (6-11) | C36H49N7O7S | 61123-13-5 | Details |
| [Asp371] Tyrosinase(369-377), human | C42H66N10O16S2 | 168650-46-2 | Details |
| pp60 c-src (521-533) | C62H94N16O25 | 198754-34-6 | Details |
| Akt Specific Substrate Peptide, Akt/PKB | C36H59N13O9 | 276680-69-4 | Details |
| [Pyr5]-Substance P (5-11) | C41H57N9O9S | 56104-22-4 | Details |
| Tyr-W-MIF-1 | C27H32N6O5 | 144450-13-5 | Details |
| S-F-L-L-R | C30H50N8O7 | 141685-53-2 | Details |
| Caspase 1 Substrate 2m (ICE), fluorogenic; Ac-YVAD-AMC | C33H39N5O10 | 149231-65-2 | Details |
| Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC | C30H37N5O13 | 169332-61-0 | Details |
| Phosphatase Substrate | C6H9NNaO7P | 333338-18-4 | Details |
| pp60(v-SRC) Autophosphorylation Site, Protein Tyrosine Kinase Substrate | C66H109N23O23 | 81493-98-3 | Details |
| FluM1 A2 (58-66) | C49H75N9O11 | 141368-69-6 | Details |
| D-Ala-D-Ala | C6H12N2O3 | 923-16-0 | Details |
| Adrenorphin | C44H69N15O9S | 88377-68-8 | Details |
| 228544-21-6 | C45H55N9O12 | 228544-21-6 | Details |
| N-Formyl-Met-Leu-Phe-Lys | C27H43N5O6S | 67247-11-4 | Details |
| RFDS | C22H33N7O8 | 102567-19-1 | Details |
| [Arg8]-Vasotocin | C43H67N15O12S2 | 113-80-4 | Details |
| Neurotensin (9-13) | C32H52N8O7 | 60482-96-4 | Details |
| Neurotensin (1-11) | C66H99N19O18 | 74032-89-6 | Details |
| Dansyl-Y-V-G | C28H34N4O7S | 113527-49-4 | Details |
| p60c-src Substrate I | C44H60N8O11 | 165190-42-1 | Details |
| MMP-7 Substrate I, fluorogenic | C52H77N17O14 | 172666-82-9 | Details |
| AKT/PKB/Rac - Protein Kinase Substrate | C74H114N28O20 | 324029-01-8 | Details |
| Valorphin | C44H61N9O11 | 144313-54-2 | Details |
| [Tyr0]-Urocortin (rat) | 187111-93-9 | Details |
| Protein Kinase C Substrate | C51H100N22O11 | 105802-82-2 | Details |
| Biotin-(Arg8)-Vasopressin | C56H79N17O14S3 | 126703-17-1 | Details |
| Neurotensin (1-8) | C46H71N13O14 | 80887-44-1 | Details |
| Orn8, Urotensin II, human | C63H83N13O18S2 | 479065-85-5 | Details |
| Urotensin I | C210H340N62O67S2 | 83930-33-0 | Details |
| Protein Kinase p34(cd2) Substrate; CSH 103 | C106H172N32O32 | 135546-44-0 | Details |
| Urocortin (rat) (free acid) | C206H338N62O64 | 171543-83-2 | Details |
| Hepcidin-1 (mouse) trifluoroacetate salt | C111H169N31O35S8 | 1676104-75-8 | Details |
| Tyrosinase (192-200) (human, mouse) | C54H77N13O17 | 170294-35-6 | Details |
| TRH-AMC | C26H28N6O6 | 190836-86-3 | Details |
| [Glu2]-TRH | C15H22N4O6 | 85541-78-2 | Details |
| TRH, Free Acid | C17H24N6O4 | 34367-54-9 | Details |
| [Pyr6,Pro9]-Substance P (6-11) | C39H53N7O7S | 79775-19-2 | Details |
| MMP-8 Substrate, fluorogenic | C49H63N13O13 | 135662-05-4 | Details |
| Myelopeptide-2 (MP-2) | C56H84N14O13 | 135861-77-7 | Details |
| Adrenorphin, Free Acid | C44H68N14O10S | 88866-92-6 | Details |
| Prepro TRH (178-199) | C116H176N28O39S | 122018-92-2 | Details |
| VIP, Antagonist | C154H257N49O40S | 125093-93-8 | Details |
| Crystalline | C13H15N3O3 | 7360-09-0 | Details |
| Protein Kinase A Substrate | C34H64N14O11 | 57836-10-9 | Details |
| Ac-YVAD-pNA | C29H36N6O10 | 149231-66-3 | Details |
| Boc-GRR-AMC | C29H44N10O7 | 113866-14-1 | Details |
| MMP Substrate I, fluorogenic | C45H64N14O11 | 121282-17-5 | Details |
| R-G-E-S | C16H29N7O8 | 93674-97-6 | Details |
| N-Formyl -Met-Ala-Ser | C12H21N3O6S | 17351-32-5 | Details |
| dY-V-G | C16H23N3O5 | 86030-52-6 | Details |
| Product Total： Product Page： | ||||
| 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||